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ABSTRACT
Objective To describe the quality of care for chronic
diseases among older people in care homes (nursing and
residential) compared with the community in a pay for
performance system.
DesignRetrospectiveanalysisofTheHealthImprovement
Network (THIN), a large primary care database.
Setting326EnglishandWelshgeneralpractices,2008-9.
Participants10387residentsofcarehomesand403259
residentsinthecommunityaged65to104andregistered
for 90 or more days with their general practitioner.
Main outcome measure 16 process quality indicators for
chronic disease management appropriate for vulnerable
olderpeopleforconditionsincludedintheUKQualityand
Outcomes Framework.
Results After adjustment for age, sex, dementia, and
lengthofregistration,attainmentofqualityindicatorswas
significantly lower for residents of care homes than for
thoseinthecommunityfor14of16indicators.Thelargest
differences were for prescribing in heart disease (β
blockersincoronaryheartdisease,relativerisk0.70,95%
confidence interval 0.65 to 0.75) and monitoring of
diabetes (retinal screening, 0.75, 0.71 to 0.80).
Monitoring hypothyroidism (0.93, 0.90 to 0.95), blood
pressure in people with stroke (0.92, 0.90 to 0.95), and
electrolytes for those receiving loop diuretics (0.89, 0.87
to 0.92) showed smaller differences. Attainment was
lower in nursing homes than in residential homes.
Residents of care homes were more likely to be identified
by their doctor as unsuitable or non-consenting for all
Quality and Outcomes Framework indicators for a
conditionallowingtheirexclusionfromtargets;33.7%for
stroke and 34.5% for diabetes.
ConclusionThereisscopeforimprovingthemanagement
of chronicdiseases in care homes,but highattainmentof
some indicators shows that pay for performance systems
do not invariably disadvantage residents of care homes
comparedwith those living in the community. High useof
exception reporting may compromise care for vulnerable
patient groups. The Quality and Outcomes Framework,
and other pay for performance systems, should monitor
attainment and exception reporting in vulnerable
populations such as residents of care homes and
consider measures that deal with the specific needs of
older people.
INTRODUCTION
In2004theUnitedKingdomintroducedapayforper-
formance contract for primary care, the Quality and
Outcomes Framework. This incentive programme
includes several detailed evidence based clinical indi-
catorsforthemanagementofchronicdisease,andper-
formance on these indicators to specified thresholds
triggers additional payments to practices. Such pay-
ments account for about a quarter of the income for
primary care practices. Introduction of the scheme
led to initial improvement and high levels of attain-
ment for included quality indicators.
1 The scheme
allows doctors to identify patients who are not appro-
priate for, or refuse, an intervention and therefore
failure to achieve standards for these patients does
not impact on remuneration. Evidence does not sug-
gest widespread inappropriate use of exception
reporting.
2
An international concern is that older people do not
receive appropriate management of chronic diseases
despite specific interventions being effective in this
population.
3 Care for chronic diseases in nursing and
residentialhomesisprovidedbygeneral(family)prac-
tices and incentivised by the Quality and Outcomes
Framework on the same basis as people living in the
community. Studies on older people in nursing and
residentialhomesarelimited,withfewstudiesallowing
explicit comparison with community dwelling resi-
dents in large samples.
4-8 Furthermore, older residents
ofcarehomesarenotroutinelyidentifiedormonitored
inUKprimarycaresystemsorintheQualityandOut-
comes Framework. This means that information on
whethervulnerableolderpeopleincarehomesbenefit
from the UK pay for performance system is lacking.
Weexaminedthequalityofcareforchronicphysical
diseases among older people in care homes and the
community, focusing on process measures that have
been identified as appropriate for vulnerable older
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Quality and Outcomes Framework.
910 Specifically,
we tested the hypotheses that in a pay for performance
system,qualityofchronicdiseasecareispoorerincare
homesandthatresidentsofcarehomesaremorelikely
to be excluded, for payment purposes, from quality
targets.
METHODS
The Health Improvement Network (THIN) is an
established primary care database that collects anon-
ymised data from a volunteer sample of UK general
practices using the Vision primary care computer sys-
tem. The database includes a full record of patient
registration, consultation, diagnoses, and prescribing
for all patients from participating practices.
1112 A fea-
ture of The Health Improvement Network database is
the family number, which allows practices to link
patients who live in the same household or institution.
Of 349 English and Welsh practices providing data
to The Health Improvement Network between March
2008 and February 2009, we excluded 19 where, for
technical reasons, less than 80% of patients had suc-
cessful postcode linkage and four that could not pro-
vide complete data over the past two years. Our initial
sample included 435568 patients aged 65 and over in
326 practices.
Identifying residents in care homes
Care homes in the United Kingdom are classified as
either nursing homes, providing 24 hour nursing care
in addition to assistance with activities of daily living,
or residential homes, providing help with activities of
daily living but not required to provide care by regis-
tered nurses. Residential homes are the equivalent to
settings referred to as assisted living facilities in other
countries. Care homes do not include older people’s
residential communities or supported housing pro-
jects. Residential and nursing homes in the United
Kingdom are registeredand regulated by national reg-
ulatory organisations. Based on address lists obtained
from the regulatory bodies, we commissioned anon-
ymised postcode linkage to identify people who lived
in postcodes that included a nursing or residential
home.
Weidentifiedresidentsofcarehomesonthebasisof
thepresenceofeitheraspecificrecordofresidenceina
carehomeoratleasttwootherindependentmarkersof
residence in a care home: registered address in a care
home postcode, a family number with four or more
olderpeopleinahousehold,orarecordofconsultation
in a care home. This approach identified 11547 resi-
dents in care homes aged 65 and over. We identified
4403(38.1%)residentsdirectlythroughaspecificRead
code for care home residence in their clinical record
and a further 7144 (61.9%) through the independent
markers.Wehavepreviouslyshownthatpatientsiden-
tified through markers are demographically similar to
those identified with specific Read codes and that our
enhanceddetectionidentifiesabout70%ofresidentsin
care home.
13 Of these residents 10985 were in
generalistcarehomesforolderpeopleandtheremain-
ing 562 were resident in specialist care homes for alco-
hol related problems, learning disabilities, and mental
health problems.
A further 405107 patients with no care home mar-
kers or shared household identifier with patients with
care home markers, were identified as resident in the
community. We excluded 18914 people whose resi-
dential status was uncertain, as their record either
included one marker of care home residence or post-
code linkagedata were not available or theylived with
two other older people. This ensured that the commu-
nitycomparisongroupdidnotincluderesidentsincare
homes. Most of these excluded people were not resi-
dentincarehomesbutsimplylivedinpostcodeswitha
care home.
Participants
Forthisanalysisweincludedresidentsinnon-specialist
carehomesandcommunitydwellingpeopleaged65to
104 who were registered for at least 90 days with their
generalpractitioner;10387residentsincarehomesfor
older people and 403259 older people in the commu-
nity.
Weidentifiedcarehometypethroughpostcodelink-
age, which distinguished whether the care home in the
postcode was a nursing home or residential home.
Some residents in care homes were not classifiable
(n=1403)astheywereidentifiedwithoutpostcodelink-
age or their postcode contained both residential and
nursing homes.
Approach to identifying quality indicators
We identified Quality and Outcomes Framework pro-
cess quality measures for coronary heart disease,
stroke, atrial fibrillation, and diabetes, which had
equivalent measures in the Rand Institute Assessing
Care of Vulnerable Elders (ACOVE-3) quality indica-
tors (see web extra appendix).
9 These quality indica-
tors were specifically developed by consensus
methods as suitable for vulnerable older people, and
asubsetofAssessingCareofVulnerableEldersquality
indicators are further identified as suitable for patients
with advanced dementia and poor prognosis.
14 This
approach ensured that the Quality and Outcomes Fra-
mework indicators included in our study were appro-
priate and suitable for older people in care homes. We
alsoincludedQualityandOutcomesFrameworkmea-
sures on monitoring of hypothyroidism and blood
pressure in chronic disease and Assessing Care of
Vulnerable Elders quality indicators on monitoring
electrolytes.
Exception reporting in the Quality and Outcomes
Framework
Exception reporting is a mechanism that allows prac-
tices to exclude patients from quality standards in the
Quality and Outcomes Framework.
15 Patients may be
exceptionreportedasinappropriateorrefusingreview
fora wholediseasearea such ascoronaryheartdisease
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cific intervention—for example, as a result of aspirin
intolerance; and where a service is not available or a
specific intervention refused. In addition, patients are
excluded for definitional reasons from indicators if
they are, for example, newly registered or have a new
diagnosis.
Approach to measuring quality indicators
For calculating indicator achievement for this study,
we excluded patients exception reported as a result of
contraindication for a specific intervention or unavail-
ability of a service or refusal of a specific intervention,
andpatientswhodidnotmeetthedefinitionalrequire-
mentsfor an indicator, but we didnot exclude patients
exceptionreportedasinappropriateorrefusingreview
foradiseasearea(diseasewideexceptions).Forindica-
torsnot included in the Qualityand OutcomesFrame-
work, we developed definitions in line with the
approach taken in the framework.
We also undertook analysis excluding all patients
with exceptions, including disease wide exceptions,
and, for comparability with nationally published
attainment in the Quality and Outcomes Framework,
we calculated attainment using the remuneration rules
of the framework, which exclude or except patients
only if they fail to meet the quality standard. We also
reportseparatelytheproportionofpatientsineachdis-
ease group who were identified with disease wide
exceptions.
Statistical analysis
Achievement of quality indicators was directly age and
sex standardised in five year age bands to the combined
nursing and residential care home population, with con-
fidence intervals calculated taking account of practice
clustering using robust variance estimates. Indicators
are shown for all residents in care homes and separately
for residents without a recorded diagnosis of dementia.
We repeated analyses excluding patients with less than
15months’registrationwiththeirgeneralpractitionerto
exclude those with poor life expectancy (data not
shown). Adjusted analysis was undertaken using a log
binomial generalised estimating equation model,
w h i c hi n c l u d e da g e( i nf i v ey e a ra g eb a n d se n t e r e da s
categories), sex,dementia diagnosis, and lengthof regis-
tration (>15 months or <15 months). Risk ratios and
95%confidenceintervalsforthesemodelsarepresented
for comparisons between residents in care homes and
thoseinthecommunity.
16 Practice effectswere included
in this model, assuming an exchangeable correlation
structure.
RESULTS
Table 1 shows the characteristics of the residents in
care homes and the community.
Disease management
After adjustment for age and sex, use of antiplatelet
therapy or anticoagulation by patients with heart dis-
ease, stroke, or atrial fibrillation was slightly lower in
nursing and residential homes than in the community.
For example, 87.6% of residents in the community
received antiplatelet therapy for coronary heart dis-
ease compared with 83.6% in care homes. Prescribing
of angiotensin converting enzyme inhibitors and β
blockers was noticeably lower for residents with heart
disease in care homes (54.7% v 34.4% for β blockers,
78.4%v55.5%forangiotensinconvertingenzymeinhi-
bitors). Use of angiotensin converting enzyme inhibi-
tors was also lower in residents in care homes with
heart failure (figure and table 2).
Disease monitoring
Residents in care homes with diabetes were less likely
to have a record of glycated haemoglobin being mea-
sured and much less likely to have a record of retinal
screening or peripheral pulses being assessed com-
pared with community dwelling residents (94.3% v
79.4% for glycated haemoglobin, 82.3% v 52.4% for
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Residentsincarehomestakingangiotensinconverting
enzyme inhibitors or loop diuretics were less likely to
have their electrolytes monitored in the past year
(81.9%v71.6%forloopdiuretics)andresidentstreated
for hypothyroidism were less likely to have had thyr-
oid function tests. Blood pressure was slightly less
likely to be recorded in the past year in residents in
care homes with stroke, diabetes, or hypertension (fig-
ure and table 2).
Effect of dementia, length of registration, and type of care
home
Residents in care homes without dementia were more
likely to achieve the quality indicators, but the differ-
ences between care homes and the community per-
sisted after exclusion of residents with dementia
(table 2). Restricting analysis to people with at least
15 months’ registration with their general practitioner
madelittledifferencetoeithertheabsolutevalueorthe
difference between settings.
After adjustment for age, sex, dementia, length of
registration,and practice, attainment of quality indica-
tors was significantly lower (P<0.002) in care homes
for all indicators except use of β blockers in heart fail-
ureand useofaspirinoranticoagulationinatrialfibril-
lation (table 2). The adjustedrisk ratios for receipt of β
blockers in coronary heart disease was 0.70 (95% con-
fidence interval 0.65 to 0.75), for retinal screening in
diabeteswas0.75(0.71to0.80),formonitoringofthyr-
oidfunctioninhypothyroidismwas0.93(0.90to0.95),
and for monitoring of electrolytes in residents taking
loop diuretics was 0.89 (0.87 to 0.92).
Forresidentialhomesalone,12of16indicatorswere
significantly lower than those for the community and
for nursing homes alone 15 indicators were signifi-
cantly lower (figure). Overall, after adjustment, aside
from use of β blockers in heart failure, all quality indi-
cators werelesslikely tobeachievedin nursinghomes
than in residential homes (figure).
Exception reporting
Table 3 shows the proportion of patients identified as
either unsuitable or dissenting from all indicators for
eachcondition.Diseasewideexceptionratesincreased
in the community with age. After standardisation for
age and sex, the proportion of residents with disease
wide exceptions was noticeably higher in care homes
for all conditions, with 33.7% of residents in care
homes with stroke excepted from calculation of Qual-
ity and Outcomes Framework target payments com-
pared with 16.9% in the community, and 34.5%
compared with 9.2% for diabetes (table 3). This differ-
ence persisted after exclusion of people with a demen-
tia diagnosis and limiting analysis to residents with a
minimum of 15 months’ registration. Exception
reporting was much higher in nursing homes than in
residential homes.
The effect of exception reporting on attainment of
quality indicators and differences between care
homes and the community was examined by exclud-
ing all excepted patients from calculation of the rele-
vant quality indicators. After these exclusions, the
differences between care home and community dwell-
ing residents remained statistically significant for all
indicators except use of anticoagulation in atrial fibril-
lation and β blockers in heart failure.
Table 1 |Characteristics of community dwelling residents and those in care homes aged 65 to 104 with at least 90 days’
registration with a general practice (n=413 646). Values are numbers (standardised percentages*) unless stated otherwise
Characteristics Community All care homes Residential homes Nursing homes
No (%) of patients 403 259 (100) 10 387 (100) 4715 (100) 4269 (100)
Mean age (years) 74.7 85.5 86.1 84.9
No (crude %) of men 180 658 (44.8) 2405 (23.2) 975 (20.7) 1103 (25.8)
No (crude %) registered for 15 months 394 677 (97.9) 8373 (80.6) 3881 (82.3) 3296 (77.2)
Patient groups†:
Coronary heart disease 68 843 (20.2) 1980 (19.1) 904 (19.2) 787 (18.4)
Myocardial infarct‡ 8513 (2.5) 314 (3.0) 147 (3.1) 121 (2.9)
Heart failure with left ventricular dysfunction 8637 (3.8) 368 (3.5) 188 (3.9) 125 (2.9)
Stroke or transient ischaemic attack 17 650 (6.3) 1854 (17.9) 694 (15.0) 907 (21.1)
Ischaemic stroke 9308 (3.3) 1073 (10.3) 387 (8.4) 547 (12.7)
Atrial fibrillation 29 710 (12.1.) 1396 (13.4) 594 (12.4) 587 (13.8)
Diabetes 52 331 (11.2) 1397 (13.5) 612 (13.5) 578 (13.3)
Hypothyroidism 34 165 (11.0) 1246 (12.0) 600 (12.4) 485 (11.6)
Hypertension 196 631 (56.1) 4446 (42.8) 2065 (43.5) 1726 (40.6)
Taking angiotensin converting enzyme
inhibitors§
149 100 (38.3) 2417 (23.3) 1143 (24.5) 889 (20.7)
Taking loop diuretics§ 41 122 (19.5) 2874 (27.6) 1439 (30.1) 1083 (25.6)
Dementia 6450 (3.7) 4256 (41.0) 1892 (40.1) 1870 (43.6)
*Directly age and sex standardised to combined care home population.
†Patient groups are based on Quality and Outcomes Framework definitions for calculation of attainment of quality standards and are not necessarily
disease prevalence.
‡Since 1 April 2003.
§Based on prescription in past six months.
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remunerable attainment was also examined. The
application of Quality and Outcomes Framework
exception rules allowed practices to obtain much
higher remunerable attainment in care homes. For
example, crude uptake of retinal screening in diabetes
rosefrom60.5%to76.6%anduseofβblockersinheart
disease from 33.7% to 45.9%.
Attainmentofqualityindicatorsinthecommunityin
the study sample, calculated using the remuneration
rules of the Quality and Outcomes Framework,
showed good agreement with nationally published
Quality and Outcomes Framework attainment.
DISCUSSION
Achievement of 14 of the 16 quality indicators was
lower for residents in care homes than for those in the
community, with the most noticeable differences for
residents of nursing homes, prescribing in patients
with heart disease, and physical monitoring of people
with diabetes. Quality indicators for use of antiplatelet
therapy and monitoring of blood pressure showed the
least difference between settings. Doctors were more
likely to exclude residents in care homes from Quality
and Outcomes Framework monitoring. Differences
between settings were not explained by higher preva-
lence of dementia in care homes, patients with limited
life expectancy, or exception reporting of patients.
Strengths and limitations of the study
This is the first study to examine quality of care for
residents in care homes since the introduction of pay
for performance in the primary care contract. Our
study deals with key limitations of existing inter-
nationalstudiesincarehomes,whichareeitherregion-
ally based or do not include a community based
comparison. Quality and Outcomes Framework
equivalent achievement in our community population
wasclosetonationalpublishedattainmentdata, which
supports the representativeness of our findings.
Table 2 |Attainment of quality indicators in community dwelling residents and those in care homes
Intervention: patient
group Source
Community Allcarehomes
All care
homes, no
dementia
Care home v
community
Appropriate
Advanced
dementia
Poor
prognosis
Crude %
(95% CI)
Standardised %*
(95% CI)
Standardised %*
(95% CI)
Standardised %*
(95% CI)
Adjusted risk ratio† (95%
CI)
Disease management
Aspirin or anticoagulants:
Coronary heart disease QOF/ACOVE 91.7 (91.3 to 92.1) 87.6 (86.8 to 88.4) 83.6 (81.5 to 85.8) 84.7 (82.2 to 87.1) 0.96 (0.94 to 0.99) Yes No
Ischaemic stroke QOF/ACOVE 95.2 (94.7 to 95.7) 93.5 (92.3 to 94.8) 88.3 (85.6 to 91.0) 90.1 (87.3 to 92.9) 0.96 (0.93 to 0.98) Yes Yes
Atrial fibrillation QOF/ACOVE 93.9 (93.4 to 94.3) 92.3 (91.6 to 93.1) 88.3 (86.2 to 90.3) 89.1 (86.9 to 91.4) 0.98 (0.96 to 1.00) Yes Yes
β blockers:
Coronary heart disease QOF/ACOVE 62.8 (61.8 to 63.7) 54.7 (53.4 to 56.0) 34.4 (32.1 to 36.8) 39.2 (36.0 to 42.4) 0.70 (0.65 to 0.75) Yes No
Heart failure QOF/ACOVE 50.3 (48.3 to 52.4) 37.8 (35.2 to 40.5) 34.4 (25.9 to 42.9) 36.0 (25.9 to 46.1) 0.93 (0.72 to 1.18) No No
Angiotensin converting
enzyme inhibitors:
Myocardial infarction QOF/ACOVE 85.5 (84.6 to 86.4) 78.4 (76.1 to 80.8) 55.5 (50.4 to 60.6) 61.4 (55.3 to 67.5) 0.76 (0.68 to 0.84) Yes No
Heart failure QOF/ACOVE 88.3 (87.5 to 89.2) 83.2 (81.4 to 85.0) 67.5 (62.1 to 72.9) 70.4 (64.3 to 76.4) 0.82 (0.75 to 0.90) No No
Disease monitoring
Blood pressure:
Stroke QOF 95.9 (95.5 to 96.3) 94.8 (94.0 to 95.6) 87.4 (85.1 to 89.8) 88.1 (85.7 to 90.5) 0.92 (0.90 to 0.95) ——
Diabetes QOF/ACOVE 98.1 (97.9 to 98.4) 97.1 (96.4 to 97.8) 91.9 (89.7 to 94.0) 93.3 (91.0 to 95.7) 0.95 (0.93 to 0.97) No No
Hypertension QOF 91.0 (90.5 to 91.6) 88.9 (88.1 to 89.6) 80.7 (78.3 to 83.0) 81.2 (78.6 to 83.7) 0.91 (0.89 to 0.94) ——
Urea and electrolytes:
Taking angiotensin
converting enzyme
inhibitor
ACOVE 85.4 (84.4 to 86.3) 82.6 (81.4 to 83.7) 75.4 (72.9 to 77.9) 76.0 (73.2 to 78.7) 0.9 1 (0.89 to 0.94) Yes Yes
Taking loop diuretic ACOVE 84.9 (84.1 to 85.8) 81.9 (80.7 to 83.0) 71.6 (69.1 to 74.1) 73.4 (70.5 to 76.3) 0.89 (0.87 to 0.92) Yes Yes
Glycated haemoglobin:
Diabetes QOF/ACOVE 96.5 (96.2 to 96.8) 94.3 (93.5 to 95.2) 79.4 (76.1 to 82.7) 82.9 (79.3 to 86.5) 0.87 (0.83 to 0.90) No No
Peripheral pulses:
Diabetes QOF/ACOVE 88.4 (87.4 to 89.3) 82.3 (80.7 to 83.8) 52.4 (47.9 to 57.0) 58.0 (53.1 to 62.8) 0.66 (0.61 to 0.72) No No
Retinal screening:
Diabetes QOF/ACOVE 88.8 (87.6 to 90.1) 83.3 (81.5 to 85.1) 59.8 (55.7 to 63.9) 64.4 (59.9 to 69.0) 0.75 (0.71 to 0.80) No No
Thyroid function tests:
Hypothyroidism QOF 96.4 (96.0 to 96.9) 94.8 (94.0 to 95.6) 87.7 (85.2 to 90.3) 87.8 (84.8 to 90.9) 0.93 (0.90 to 0.95) ——
QOF=Quality and Outcomes Framework; ACOVE=Assessing Care of Vulnerable Elders.
*Standardised to combined care home population.
†Risk ratio adjusted for age, sex, practice, dementia, and length of registration.
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residents in care homes and those in the community
is the adequacy of adjustment for important demo-
graphic and clinical differences between the popula-
tions. We adjusted all analyses for age and sex and
alsopresentanalysisstratifiedbydementia,butcannot
completely exclude the effects of residual or unmea-
sured confounding in our comparisons. However,
examination of attainment stratified by age, sex, and
dementia confirmed the lower attainment in care
homes.
Our data rely on quality of recording in the electro-
nic primary care record. As primary care computer
systems are used for repeat prescribing and laboratory
resultsaretransmittedelectronicallytopractices,these
aspects of care are likely to be fully and accurately
recorded. However, measures that require recording
at the time of consultation—for example, blood pres-
sure—may be less likely to be recorded in care homes
where contemporaneous access to practice computer
systems may not always be possible.
Appropriateness of quality indicators
Not all interventions for chronic disease are appropri-
ate for all older people, and comorbidity and life
expectancy need to be considered.
14 We addressed
this concern by separately analysing patients without
recorded dementia and restricting analysis to patients
with at least 15 months’ registration with their general
practice; thus excluding patients with limited life
expectancy. Neither analysis gave substantially differ-
ent findings. In addition, poorer attainment in care
homes persisted after exclusion of patients with any
doctor recorded exception and was seen for measures
considered appropriate for patients with advanced
dementia and poor prognosis (table 2).
The Quality and Outcomes Framework does not
include problems that are particular concerns in care
homes, such as nutrition, mobility, continence, pres-
sure ulcers, and pain.
17 Although quality indicators
for these conditions are available in the Assessing
CareofVulnerableEldersqualityindicators,theycan-
notcurrentlybemeasuredmeaningfullyusingprimary
care data in the United Kingdom. Therefore Quality
and Outcomes Framework based indicators cannot
capture fully the quality of clinical care in care
homes.Nevertheless,goodmanagementofconditions
such as stroke and diabetes is important for all older
people,irrespectiveofresidentialsetting.Forexample,
diabetes in nursing homes is associated with poor out-
comes, including hospital admission and pressure
ulcers.
18
Comparison with previous studies
Existing studies of quality of chronic disease care in
UK care homes are sparse. A small study in four nur-
sing homes in 2003, before introduction of the new
primarycarecontract,identifiedlowattainmentofsev-
eraloftheindicatorsinourstudy.
4Internationally,stu-
dies have reported poor quality of care in nursing
homesfordiabetes,heartfailure,andstrokebutusually
do not include a community comparison group.
5-8 A
recentlyreportedlarge USstudymeasuredattainment
of selected Assessing Care of Vulnerable Elders qual-
ity indicators in nursing homes in 2000 and found
lower attainment than in our study in a population
with a higher prevalence of dementia, despite taking
accountofpotentialcontraindications.
6Ourbetterper-
formance than this US study, except for monitoring of
electrolytes,may reflectboth the effect of incentives in
the Quality and Outcomes Framework and also
improvement over time. A recent large Belgian study
onprescribinginnursinghomes,withoutacommunity
comparison group, has reported higher prescribing of
β blockers and angiotensin converting enzyme inhibi-
tors in heart disease.
19
A national study of exception reporting in the Qual-
ityandOutcomesFrameworkfoundlowlevelsofover-
all exception reporting for process measures and did
not suggest widespread inappropriate overuse but
was not able to assess the experience of vulnerable
population subgroups.
2 Our findings suggest that low
overall exception rates may mask high exception rates
for patient groups that make up a small proportion of
the population.
The similarity of β blocker prescribing for heart fail-
ure in care home and community residents is unex-
pected as we have recently shown age and
socioeconomic inequity for this intervention.
20 This
new Quality and Outcomes Framework indicator, in
Table 3 |Disease wide exceptions from Quality and Outcomes Framework targets in community dwelling residents and those in care homes
Disease wide exception*
Community All care homes
All care homes
without dementia Residential homes Nursing homes
Crude %
(95% CI)
Standardised %†
(95% CI)
Standardised %†
(95% CI)
Standardised %†
(95% CI)
Standardised %†
(95% CI)
Standardised %†
(95% CI)
Coronary heart disease 4.4 (3.8 to 5.0) 10.3 (8.8 to 11.7) 29.3 (25.0. to 33.7) 23.3 (19.4 to 27.2) 26.3 (21.0 to 31.6) 34.5 (28.5 to 40.5)
Heart failure 2.4 (1.9 to 2.9) 4.6 (3.4 to 5.8) 18.8 (13.6 to 24.0) 17.5 (11.7 to 23.2) 14.8 (8.0 to 21.6) 26.3 (16.3 to 36.2)
Stroke 8.6 (7.4 to 9.7) 16.9 (14.7 to 19.2) 33.7 (29.0 to 38.3) 28.9 (24.3 to 33.4) 30.7 (24.8 to 36.6) 35.8 (29.9 to 41.7)
Atrial fibrillation 1.1 (0.9 to 1.4) 2.2 (1.7 to 2.7) 5.6 (3.7 to 7.4) 5.0 (3.0 to 7.0) 3.8 (2.1 to 5.4) 6.8 (3.9 to 9.8)
Diabetes 4.8 (4.2 to 5.3) 9.2 (7.9 to 10.6) 34.5 (29.6 to 39.4) 28.4 (23.5 to 33.2) 27.1 (21.5 to 32.7) 42.9 (35.9 to 49.9)
Hypothyroidism 0.5 (0.4 to 0.7) 0.9 (0.5 to 1.2) 4.7 (3.1 to 6.4) 4.4 (2.6 to 6.1) 4.1 (1.6 to 6.5) 4.4 (2.2 to 6.6)
Hypertension 2.0 (1.7 to 2.3) 4.1 (3.4 to 4.8) 7.9 (6.2 to 9.5) 6.7 (5.1 to 8.2) 6.8 (4.8 to 8.8) 8.4 (5.7 to 11.1)
*Among those with disease.
†Standardised to combined care home population.
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geststhatdifferencesbetweencarehomesandthecom-
munity may only emerge when an intervention has
high uptake, as is the case for the other indicators
examined.
Implications
Our study shows a need to improve care for chronic
diseases among older people in care homes, but the
absenceoflargedifferencesforsomeQualityandOut-
comes Framework indicators gives reassurance that
pay for performance systems do not invariably disad-
vantage vulnerable groups. It is notable that the only
indicator lower than the US study in nursing homes
was monitoring of electrolytes, which is not included
in the Quality and Outcomes Framework.
For some interventions, lower attainment of quality
indicators may be appropriate as a result of comorbid-
ity and poor life expectancy.
14 Most indicators in the
Quality and Outcomes Framework aim to ensure that
patientsreceiveevidence basedinterventionsforcom-
mon chronic conditions, with a strong emphasis on
improving life expectancy and reducing long term
complications.Theseobjectivesmaybelessimportant
for older people in care homes than more immediate
concerns, leading to a perception by clinicians that the
Quality and Outcomes Framework is not relevant to
residents in care homes, with resultant high disease
wide exception rates. However, such decisions need
to be explicit, individualised, and consensual and not
based on assumptions about capacity to benefit. High
disease wide exceptions suggest a less individualised
approachandmayactasadisincentivetogooddisease
management.
Notably, the disease wide exceptions mean that
patients are labelled as either unsuitable or non-
consenting from indicators that are achieved. For
example, although 43% of patients in nursing homes
were excepted from diabetes management, 73% were
reported to have been tested for glycated haemoglo-
bin. Our findings highlight a risk for pay for perfor-
mance systems that care for small, vulnerable, and
hardtomonitorgroupsmaybecompromisedbyinap-
propriate or blanket use of exception reporting.
The lower attainment on measures that require
access to blood tests and for diabetic care may reflect
difficulties in accessing services in care homes rather
than physician behaviour. Such inequity may be an
unintendedconsequenceofimprovementsintheorga-
nisation of care that are encouraged by pay for perfor-
mancesystems.IntheUnitedKingdom,therehasbeen
a move to systematic diabetic care with specialist prac-
tice based clinics and centralised diabetic retinal
screening, but these benefits may not reach residents
in carehomeswhoare not abletoattend the clinic.
21A
need exists to ensure equity of access for residents in
care homes, and other vulnerable groups, to new ser-
vice models incentivised in pay for performance sys-
tems.
A weakness of the Quality and Outcomes Frame-
work is the absence of indicators for problems with
particular relevance to people in care homes such as
pain management or continence care. Inclusion of
such measures in the framework may be problematic
for several reasons, including ease of recording or
extraction from primary care systems, and difficulty
with precise diagnosis, and the framework may not
necessarily be an appropriate vehicle for such quality
improvement.
22 However, the absence of relevant
indicators means that pay for performance incentives
do not encourage recording or reward important
aspects of care for vulnerable older people. Evidence
from the United States suggests that quality of care for
problems specific to older people is poorer than that
for other chronic diseases, and, more specifically,
areas not included in the Quality and Outcomes Fra-
mework may be relatively neglected in UK primary
care.
23-25 Given that we have shown poorer attainment
ofQualityandOutcomesFrameworkmeasuresincare
homes, it is likely that quality of care for non-incenti-
vised problems is worse. We have previously advo-
cated the separate identification of care home
residents in healthcare systems for quality monitoring,
and our findings emphasise this recommendation.
13
Our current findings support enhancement of pay for
performancesystems toinclude measures that are par-
ticularly relevant to residents of care homes and vul-
nerable older people in the community, such as those
included in the Assessing Care of Vulnerable Elders
quality indicatorsfor continence, sensory impairment,
chronic pain, and falls.
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